The multinational retail corporation Walmart that has been operating a chain of hypermarkets, discount department stores, and grocery stores has finally announced an important measure in halting the sale of Zantac drug.
Headquartered in Bentonville, Arkansas, Walmart’s move came amid the concerns of cancer-causing chemical present in Zantac drug. Henceforth, on Wednesday the company announced to join other chain stores to curb the usage of the drug, “suspending the sale of all over the counter ranitidine products in stores, clubs and online, including Zantac, Equate and Member’s Mark brands”.
Sold under its trade name, the drug is a medication which decreases stomach acid production and is commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. However, the benefits provided by the drug seems to be minimal in front of the risks on its consumption.
A product alert from the Food and Drug Administration (FDA) disclosed that ranitidine found within Zantac, could contain low levels of the carcinogen nitrosodimethylamine (NDMA), bringing its disadvantages in public notice. Walmart’s move was in response to the food alert review.
While warning the citizens, the Walmart company officials appealed to the customers that they could return the purchased Zantac drugs back to Walmart or Sam’s Club, instead of consuming it and could also claim for their refunds.
Out of caution, another retail and health care company’s subsidiary branch CVS Pharmacy, took a step forward in halting the sales of the over-the-counter heartburn drug Zantac on Monday. Although the company said that “the FDA is not recommending that patients stop taking ranitidine at this time”.
Sanofi, the company that makes Zantac, said in a statement that the amounts of the carcinogen NDMA in Zantac drug found by the FDA “barely exceed amounts found in common foods.”
“We are working closely with the FDA and are conducting our own robust investigations to ensure we continue to meet the highest quality safety and quality standards,” the company said. Well, the actions imposing such bans are deemed to affect the market of Zantac.
With its current move, Walmart has now become the fourth company joining the CVS Health, Walgreens and Rite Aid, banning the sale of Zantac drug. Meanwhile, they are pleading the patients to consume other over-the-counter heartburn drugs, but the question is whether other drugs are safe enough to be used by humans?